News|Articles|June 1, 2003

Iressa (Gefitinib) ASTRAZENECA

Treatment for lung cancer patients unresponsive to chemotherapy


Related to this article

Stafeeva-stock@adobe.com
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.